DarioHealth (DRIO) Tops Q1 EPS by 8c

DarioHealth (NASDAQ: DRIO) reported Q1 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53). Revenue for the quarter came in at $7.07 million versus the consensus estimate of $6.89 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance